Morgens Waterfall Vintiadis & Co’s CVS Health CVS Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,800	Closed	-$1.41M	–	41
2022 Q3	$1.41M	Hold	14,800	–	–	1.55%	20
2022 Q2	$1.37M	Sell	14,800 -6,500	-31%	-$634K	1.29%	26
2022 Q1	$2.16M	Buy	21,300 +5,600	+36%	+$588K	1.36%	21
2021 Q4	$1.62M	Hold	15,700	–	–	0.87%	25
2021 Q3	$1.33M	Hold	15,700	–	–	0.69%	30
2021 Q2	$1.31M	Buy	+15,700	New	+$1.29M	0.67%	29
2016 Q3	–	Sell	-30,000	Closed	-$2.87M	–	46
2016 Q2	$2.87M	Hold	30,000	–	–	2.66%	12
2016 Q1	$3.11M	Hold	30,000	–	–	2.16%	11
2015 Q4	$2.93M	Sell	30,000 -12,000	-29%	-$1.18M	1.23%	21
2015 Q3	$4.05M	Buy	+42,000	New	+$4.42M	2.23%	11
2014 Q2	–	Sell	-50,000	Closed	-$3.74M	–	40
2014 Q1	$3.74M	Hold	50,000	–	–	2.27%	21
2013 Q4	$3.58M	Buy	+50,000	New	+$3.21M	2.45%	17

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's CVS Position: Q4 2022 in Review

Morgens Waterfall Vintiadis & Co sold out of CVS Health (CVS) in Q4 2022, closing a stake of 14,800 shares — an estimated $1.41M sold.

Morgens Waterfall Vintiadis & Co first reported a position in CVS in Q4 2013 and held it in 12 quarters. The position peaked at $4.05M in Q3 2015. 2,406 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

Morgens Waterfall Vintiadis & Co reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
Morgens Waterfall Vintiadis & Co sold 14,800 CVS Health shares in Q4 2022, an estimated $1.41M.
Morgens Waterfall Vintiadis & Co first reported a position in CVS Health in Q4 2013 and held it in 12 quarters.
Morgens Waterfall Vintiadis & Co's CVS Health position peaked at $4.05M in Q3 2015.
2,406 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q4 2022, filed 14 Feb 2023.